Citi upgraded Mettler-Toledo (MTD) to Neutral from Sell with a price target of $1,300, up from $1,200. The firm cites the stock’s valuation reset for the upgrade and says fiscal 2025 numbers look reasonable following the initial guide last quarter. Heading into 2025, investor appetite for life science tools and diagnostics remains light, but there are “pockets of areas to be more constructive such as bioprocessing where the recovery is underway,” the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MTD:
- Mettler-Toledo price target lowered to $1,450 from $1,550 at Stifel
- Mettler-Toledo price target lowered to $1,310 from $1,375 at Baird
- Mettler-Toledo price target lowered to $1,350 from $1,400 at Wells Fargo
- Mettler-Toledo Reports Modest Growth in Q3 2024
- Mettler-Toledo price target lowered to $1,315 from $1,330 at Goldman Sachs